Jeremy Duffield

Insider Reports History

Entity
Individual
Location
Prime Medicine, Inc., 21 Erie St., Cambridge, MA
Signature
/s/ Karen Brown, attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Jeremy Duffield:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Prime Medicine, Inc. Chief Scientific Officer Stock Option (right to buy) 181K Feb 21, 2024 Direct

Insider Reports Filed by Jeremy Duffield

Symbol Company Period Transactions Value $ Form Type Date Filed Role
PRME Prime Medicine, Inc. Feb 21, 2024 1 $0 4 Feb 23, 2024 Chief Scientific Officer
PRME Prime Medicine, Inc. Mar 31, 2023 1 $0 4 Apr 4, 2023 Chief Scientific Officer
PRME Prime Medicine, Inc. Oct 19, 2022 0 $0 3 Oct 19, 2022 Chief Scientific Officer